English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jan 13, 2026

KAIST researchers trace origin cell for aggressive IDH-mutant glioma
+ Pharmaceuticals
Patient Daily | Jan 13, 2026

Shinshu University researchers develop engineered “super-probiotic” with enhanced gut adhesion
+ Pharmaceuticals
Patient Daily | Jan 13, 2026

Scientists map how stem cell therapies could rebuild damaged neural circuits after stroke
+ Pharmaceuticals
Patient Daily | Jan 13, 2026

American Lung Association criticizes EPA’s new rule on gas-fired power plant emissions
+ Pharmaceuticals
Patient Daily | Jan 13, 2026

J.P. Morgan Healthcare Conference spotlights obesity drugs and Q4 sales growth
+ Pharmaceuticals
Patient Daily | Jan 13, 2026

Novartis explains cautious approach toward GLP-1 drugs amid crowded market
+ Pharmaceuticals
Patient Daily | Jan 13, 2026

Penn Medicine launches AI-based initiative for personalized clinical training
+ Pharmaceuticals
Patient Daily | Jan 13, 2026

AbbVie announces $100B investment in US R&D and manufacturing

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes